Angiotensin System Inhibitors in Renal Cell Carcinoma-Letter

Clinical Cancer Research

Volumn 22, Issue 2, 2016, Pages 524-

  Huillard, Olivier ^a   Xylinas, Evanguelos ^a   Peyromaure, Michael ^a   Alexandre, Jerome ^a   Goldwasser, Francois ^a  

^a université Paris Cité   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANTIHYPERTENSIVE AGENT; SORAFENIB; SUNITINIB; VASCULOTROPIN INHIBITOR; ANGIOTENSIN DERIVATIVE;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; BODY MASS; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFICACY; HUMAN; HYPERTENSION; KIDNEY METASTASIS; LETTER; MUSCLE MASS; MUSCLE STRENGTH; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; SARCOPENIA; SIDE EFFECT; TREATMENT DURATION; TUMOR MICROENVIRONMENT; ANTAGONISTS AND INHIBITORS; CARCINOMA, RENAL CELL; DRUG EFFECTS; FEMALE; MALE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSINS; CARCINOMA, RENAL CELL; FEMALE; HUMANS; MALE; RENIN-ANGIOTENSIN SYSTEM;

EID: 84959017289     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-15-2102     Document Type: Letter

References (5)

1. McKay RR, Rodriguez GE, Lin X, Kaymakcalan MD, Hamnvik OP, Sabbisetti VS, et al. Angiotensin system inhibitors and survival outcomes in patients with metastatic renal cell carcinoma. Clin Cancer Res 2015;21:2471-9.
2. Emile G, Pujade-Lauraine E, Alexandre J. Should we use the angiotensinconverting enzyme inhibitors for the treatment of anti-VEGF-induced hypertension? Ann Oncol 2014;25:1669-70.
3. Huillard O, Mir O, Peyromaure M, Tlemsani C, Giroux J, Boudou-Rouquette P, et al. Sarcopenia and body mass index predict sunitinibinduced early dose-limiting toxicities in renal cancer patients. Br J Cancer 2013;108:1034-41.
4. Antoun S, Baracos VE, Birdsell L, Escudier B, Sawyer MB. Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol 2010;21:1594-8.
5. Onder G, Penninx BW, Balkrishnan R, Fried LP, Chaves PH, Williamson J, et al. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet 2002;359:926-30.